Labcorp Holdings Inc. (LH)
NYSE
Closed
Oct 23, 2026
Day's Range
326.8352 wk Range
244.52Overview - LH - Labcorp Holdings Inc.
Key Statistics
Valuation
Enterprise Value
32.28B
P/E (Trailing)
26.09
P/E (Forward)
15.90
PEG Ratio
0.91
Price / Sales (TTM)
1.78
Price / Book
2.96
EV / EBITDA
13.91
Profitability
Gross Margin
29.80%
Profit Margin
6.98%
Operating Margin
12.24%
Return on Assets
5.52%
Return on Equity
11.72%
Ownership
Shares Outstanding
80.90M
Float
80.71M
Short % of Shares Outstanding
3.32%
Held by Insiders
0.34%
Held by Institutions
101.78%
Price stats
Beta
0.84
50-Day Avg
319.95
200-Day Avg
282.09
Dividends
Payout Ratio
23.82%
Frequency
Quarterly
Analyst Consensus
18 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LH - Labcorp Holdings Inc.
Peers - LH - Labcorp Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
Profile Summary - LH - Labcorp Holdings Inc.
About
Labcorp Holdings Inc. is a global life sciences and healthcare company that provides laboratory services to support clinical care, research, and drug development. Labcorp Holdings Inc. serves doctors, hospitals, pharmaceutical companies, researchers, and patients through a broad portfolio that includes routine and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
